BostonSight with scientific advisory board

December 10, 2020 Posted by BostonSight


“BostonSight has always pursued excellence and pushed the limits when it comes to understanding corneal health,” said Sara Yost, BostonSight President and CEO. “As leaders in the eye health industry, we’re excited to bring together medical experts to provide expertise and guidance as we plan future studies that will advance the understanding, treatment, and care of complex corneal disease.”

 The BostonSight Scientific Advisory Board, chaired by Dan Brocks, MD, BostonSight’s Chief Medical Officer, includes Yost along with Demi Niforos, MS, Vice President of Biostatistics and Statistical Programming at eClinical Solutions; Michael Raizman, MD, a practitioner at Ophthalmic Consultants of Boston and Associate Professor of Ophthalmology at Tufts University School of Medicine; Ali Djalilian, MD, Professor of Ophthalmology, Cornea Service and Director of the Stem Cell Therapy and Corneal Tissue Engineering Laboratory at Illinois Eye and Ear Infirmary; and Gloria B. Chiu, OD, FAAO, FSLS, Associate Professor of Clinical Ophthalmology at the USC Roski Eye Institute, Department of Ophthalmology at the University of Southern California Keck School of Medicine.

“Our research program brings together BostonSight, our partners, and patients to improve existing treatments and explore cutting-edge therapeutic modalities for corneal disease,” said Brocks. “A robust research program pushes the industry forward by educating the medical community and inspiring new treatment protocols, ultimately improving patient outcomes.”

Next entry: Technoteam and TRIOPTICS announce partnership

Previous entry: EFCLIN Congress takes place in 2022

Leave a comment:

Commenting is not available in this weblog entry.